Identification of the Sentinel Lymph Node Applied in Breast Cancer

吴萍,杨勇,欧敬民,姜宏华,杜隽铭,朱健

DOI: https://doi.org/10.3969/j.issn.1674-8115.2003.z1.018

2003-01-01

Abstract:Objective To evaluate the feasibility of two methods in identification of the sentinel lymph node(SLN) from the breast cancer patients, either filtered technetium -labeled colloid and gamma probe or blue dye. Methods A total of 42 patients who suffered from breast cancer, with the largest dimension of the tumor 5cm and negative axillary nodes in physical examination were divided into two groups randomly. Filtered technetium -labeled colloid and gamma probe was used to identify SLNs in group one (20 patients) , in which 6 of them had lymphoscintigraphy, whereas blue dye was used in the subareolar in the group two (22 cases). All of them were performed sentinel lymph nodes biopsy before axillary dissection. Results There were 29 out of 42 (69.05% ) positive identification of SLNs. There were 15 out of 20 (75% ) positive identifications of SLNs in the group one; whereas there were 14 out of 22 (63. 64% ) positive in the group two. In the second group there is a significant correlation between age and positive identifications of SLNs. Conclusion It is feasible to identify the SLNs, using technetium -labeled colloid or blue dye. Positive identification of the SLNs, however, is depended on a number of factors: techniques applied, the competency of the performer, and the patients conditions.